)
)
NeuroSense Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from NeuroSense Therapeutics Ltd
Access all reports
NeuroSense Therapeutics Ltd is a biotechnology company focused on developing treatments for neurodegenerative diseases. The company specializes in multi-target drug therapies designed to address conditions such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and Alzheimer’s disease. The company is headquartered in Herzliya, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Axon: Making Bullets Obsolete
Axon transformed the TASER from a struggling invention into a $50B public safety giant, redefining policing with tech-driven solutions.
21 Feb 2025
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
Ticker symbol
NRSN
Country
🇺🇸 United States